CJC-1295 / Ipamorelin Blend (No DAC) – 99%+ Purity
Combined synthetic CJC-1295 (No DAC variant, GHRH analog) and Ipamorelin (synthetic ghrelin-mimetic) research peptide blend. Independently third-party tested. Available in 5/5mg and 10/10mg lyophilized configurations.
Price range: $74.99 through $139.99
5/5 | 10/10
- Same-day shipping on orders placed before 12:00 PM EST. Free U.S. shipping on orders over $200.
- 99%+ Verified Purity
- COA on Every Lot
- Same-Day U.S. Shipping
- For Research Use Only
What Is CJC-1295 / Ipamorelin Blend (No DAC)?
The CJC-1295 / Ipamorelin Blend (No DAC) is a combined research peptide product that includes CJC-1295 (a synthetic growth-hormone-releasing hormone (GHRH) analog research peptide) without the Drug Affinity Complex (DAC) modification, plus Ipamorelin (a synthetic ghrelin-mimetic research peptide) in a single research vial. The blend has been examined in preclinical research literature as a combined GHRH-analog plus ghrelin-mimetic research model.
The CJC-1295 / Ipamorelin (No DAC) research peptide blend supplied by Genryse is synthesized to a verified 99%+ purity threshold for each component, lyophilized for stability, and supplied strictly for in-vitro laboratory research, analytical work, and controlled scientific study. Genryse research peptide blends are not supplied for human consumption, dietary use, athletic application, anti-aging use, or veterinary application.
The blend sits within the Growth Hormone Research category alongside the CJC-1295 with DAC research peptide, the standalone Ipamorelin research peptide, and the Sermorelin research peptide.
How CJC-1295 / Ipamorelin Blend (No DAC) Is Discussed in Research
The CJC-1295 / Ipamorelin (No DAC) research peptide blend has been examined in preclinical research models. The published research literature documents investigations into the combined activity of synthetic GHRH analogs and ghrelin-mimetic research peptides in research models examining growth-hormone-axis research. None of the descriptions below describe human use, treatment outcomes, or clinical recommendations – they summarize how CJC-1295 and Ipamorelin as research peptides have been characterized in published in-vitro and animal-model studies.
Research investigators have examined CJC-1295 / Ipamorelin Blend (No DAC) in the context of:
- Combined GHRH-analog and ghrelin-mimetic research in controlled in-vitro systems
- Comparative DAC vs No DAC research in laboratory models
- GHSR-1a (ghrelin receptor) research in cell-based assays
- GHRH receptor signaling research in animal models
- Peptide stability and half-life research in defined laboratory conditions
All findings discussed in the published research literature are derived from in-vitro and in-vivo animal-model studies and are exploratory in nature. Genryse supplies CJC-1295 / Ipamorelin Blend (No DAC) as a research peptide for these laboratory-research purposes only.
CJC-1295 / Ipamorelin Blend (No DAC) Product Specifications
| Product name | CJC-1295 / Ipamorelin Research Peptide Blend (No DAC) |
| Components | CJC-1295 No DAC (synthetic GHRH analog) + Ipamorelin (synthetic ghrelin-mimetic research peptide) |
| CJC-1295 No DAC notes | Synthetic 30-amino-acid GHRH analog research peptide; lacks the Drug Affinity Complex (DAC) modification of the with-DAC variant |
| Ipamorelin notes | Synthetic 5-amino-acid pentapeptide; selective GH secretagogue research peptide |
| Form supplied | Combined lyophilized powder, vialed |
| Sizes available | 5/5mg (5mg CJC-1295 No DAC + 5mg Ipamorelin) | 10/10mg (10mg + 10mg) |
| Verified purity | 99%+ per component (HPLC) |
| Identity verification | Mass spectrometry per component |
| COA | Available for every lot, listing both components |
| Country of origin | USA |
| Intended use | In-vitro laboratory research only |
Purity, COA, and Third-Party Testing
Every Genryse CJC-1295 / Ipamorelin Blend (No DAC) research peptide is independently verified by third-party laboratories. Each batch undergoes HPLC testing for 99%+ purity and mass-spectrometry verification for molecular identity. A Certificate of Analysis is generated for every lot of CJC-1295 / Ipamorelin Blend (No DAC) we supply, and is available for review on the COA library page.
Genryse does not ship a research peptide without a COA. This is a non-negotiable element of how we supply CJC-1295 / Ipamorelin Blend (No DAC) to qualified research professionals.
📄 Download Sample CJC-1295 / Ipamorelin Blend (No DAC) COA (PDF) →CJC-1295 / Ipamorelin Blend (No DAC) Storage and Handling
Lyophilized CJC-1295 / Ipamorelin Blend (No DAC) should be stored at -20°C, protected from light, until reconstitution. Once reconstituted, CJC-1295 / Ipamorelin Blend (No DAC) should be stored at 2–8°C and used within the timeframe specified on the lot’s COA. Maintain aseptic handling practices to preserve research peptide integrity.
For comprehensive handling and reconstitution practices, refer to the Genryse peptide storage guide.
📘 View Peptide Storage Guide →Related Research Peptides
Researchers studying CJC-1295 / Ipamorelin Blend (No DAC) frequently work alongside the following research peptides supplied by Genryse:
Browse Growth Hormone Research →Research References
Selected published research literature referencing CJC-1295 / Ipamorelin Blend (No DAC):
- Teichman SL et al., J Clin Endocrinol Metab, 2006;91(3):799–805 (CJC-1295 reference)
- Raun K et al., Eur J Endocrinol, 1998;139(5):552–561 (Ipamorelin reference)
- Sjögren K et al., Growth Horm IGF Res, 2017;36:65–72 (GHRH-axis research)
- Lengyel A-MJ, Arq Bras Endocrinol Metab, 2006;50(1):1–10 (GH secretagogue research)
CJC-1295 / Ipamorelin Blend (No DAC) – Frequently Asked Questions
Warning — For Research Use Only
FDA Disclaimer: The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The research peptides supplied by Genryse are not intended to diagnose, treat, cure, or prevent any disease.
For Research Purposes Only
Not a Dietary Supplement
Not for Human Consumption
Not for Veterinary Use
